Bionano Genomics Inc
NASDAQ:BNGO
Bionano Genomics Inc
Revenue
Bionano Genomics Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bionano Genomics Inc
NASDAQ:BNGO
|
Revenue
$36.1m
|
CAGR 3-Years
62%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
Bionano Genomics Inc
Revenue Breakdown
Breakdown by Geography
Bionano Genomics Inc
Total Revenue:
36.1m
USD
|
Americas:
18m
USD
|
EMEA:
13m
USD
|
Asia Pacific:
5.1m
USD
|
Breakdown by Segments
Bionano Genomics Inc
Total Revenue:
36.1m
USD
|
Product:
26.7m
USD
|
Consumable Revenue:
11.2m
USD
|
Instrument Revenue:
10m
USD
|
Product And Service, Other:
9.4m
USD
|
Software Revenue:
5.6m
USD
|
See Also
What is Bionano Genomics Inc's Revenue?
Revenue
36.1m
USD
Based on the financial report for Dec 31, 2023, Bionano Genomics Inc's Revenue amounts to 36.1m USD.
What is Bionano Genomics Inc's Revenue growth rate?
Revenue CAGR 5Y
25%
Over the last year, the Revenue growth was 30%. The average annual Revenue growth rates for Bionano Genomics Inc have been 62% over the past three years , 25% over the past five years .